Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Treasury Shares (2017 - 2025)

Niagen Bioscience (NAGE) has disclosed Treasury Shares for 9 consecutive years, with $36000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Treasury Shares fell 94.09% to $36000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $36000.0, a 94.09% decrease, with the full-year FY2025 number at $36000.0, down 94.09% from a year prior.
  • Treasury Shares was $36000.0 for Q4 2025 at Niagen Bioscience, down from $1.5 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $1.5 million in Q1 2025 to a low of $36000.0 in Q4 2025.
  • A 4-year average of $768750.0 and a median of $680500.0 in 2023 define the central range for Treasury Shares.
  • Peak YoY movement for Treasury Shares: surged 369.46% in 2024, then tumbled 94.09% in 2025.
  • Niagen Bioscience's Treasury Shares stood at $650000.0 in 2022, then plummeted by 74.31% to $167000.0 in 2023, then soared by 264.67% to $609000.0 in 2024, then crashed by 94.09% to $36000.0 in 2025.
  • Per Business Quant, the three most recent readings for NAGE's Treasury Shares are $36000.0 (Q4 2025), $1.5 million (Q3 2025), and $1.5 million (Q2 2025).